Market revenue in 2023 | USD 185.4 million |
Market revenue in 2030 | USD 338.2 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Bronchodilators |
Fastest growing segment | Combination Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, Other Drug Classes |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Novartis AG ADR, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries, Beximco Pharmaceuticals Ltd DR, Mylan, Akorn, Apotex Inc., Nephron Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account